Condition
Ménière's Disease
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06859788Phase 3Recruiting
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
NCT05984901Not ApplicableUnknownPrimary
The CAVA Multicentre Dizziness Trial
NCT05938517Phase 1CompletedPrimary
Pharmacokinetic Profile of Betahistine With and Without Selegiline in Healthy Volunteers
NCT04438538CompletedPrimary
Ménière's Disease Registry
Showing all 4 trials